首页> 外文期刊>Oncology letters >Miconazole induces autophagic death in glioblastoma cells via reactive oxygen species-mediated endoplasmic reticulum stress
【24h】

Miconazole induces autophagic death in glioblastoma cells via reactive oxygen species-mediated endoplasmic reticulum stress

机译:咪康唑通过反应性氧物种介导的内质网胁迫诱导胶质母细胞瘤细胞中的自噬死亡

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Miconazole is an antifungal agent that is used for the treatment of superficial mycosis. However, recent studies have indicated that miconazole also exhibits potent anticancer effects in various types of cancer via the activation of apoptosis. The main aim of the present study was to observe the effect of miconazole on autophagic cell death of cancer cells. Cytotoxicity was measured by viable cell counting after miconazole treatment in glioblastoma cell lines (U343MG, U87MG and U251MG). Induction of autophagy was analyzed by examining microtubule-associated protein light chain 3 (LC3)-II expression levels using western blotting and by detecting GFP-LC3 translocation using a fluorescence microscope. Intracellular ROS production was measured using a fluorescent probe, 2 ',7 '-dichlorodihydrofluorescein diacetate. It was found that miconazole induced autophagic cell death in the U251MG glioblastoma cell line via the generation of reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress response. An association between miconazole-induced ROS production and autophagy was also identified; in particular, pretreatment of the cells with a ROS scavenger resulted in a reduction in the levels of LC3-II. Miconazole-induced ER stress was associated with increases in binding immunoglobulin protein (BiP), inositol-requiring enzyme 1 alpha (IRE1 alpha) and CHOP expression, and phospho-eIF2 alpha levels. The inhibition of ER stress via treatment with 4-phenylbutyric acid or BiP knockdown reduced miconazole-induced autophagy and cell death. These findings suggest that miconazole induces autophagic cell death by inducing an ROS-dependent ER stress response in U251MG glioma cancer cells and provide new insights into the potential antiproliferative effects of miconazole.
机译:咪康唑是一种用于治疗浅表真菌病的抗真菌药物。然而,最近的研究表明,咪康唑还通过激活细胞凋亡在各种类型的癌症中显示出强大的抗癌作用。本研究的主要目的是观察咪康唑对癌细胞自噬性细胞死亡的影响。在胶质母细胞瘤细胞系(U343MG、U87MG和U251MG)中,通过咪康唑治疗后的活细胞计数来测定细胞毒性。通过使用western blotting检测微管相关蛋白轻链3(LC3)-II的表达水平和使用荧光显微镜检测GFP-LC3易位来分析自噬的诱导。使用荧光探针2',7'-二氯二氢荧光素二乙酸酯测量细胞内ROS的产生。研究发现,咪康唑通过产生活性氧(ROS)和内质网(ER)应激反应诱导U251 MG胶质母细胞瘤细胞系的自噬性细胞死亡。咪康唑诱导的活性氧生成与自噬之间也存在关联;特别是,用活性氧清除剂预处理细胞,导致LC3-II水平降低。咪康唑诱导的内质网应激与结合免疫球蛋白(BiP)、肌醇需要酶1α(IRE1α)和CHOP表达以及磷酸化eIF2α水平的增加有关。通过4-苯基丁酸或BiP基因敲除抑制内质网应激可减少咪康唑诱导的自噬和细胞死亡。这些发现表明,咪康唑通过诱导U251 MG胶质瘤癌细胞中的ROS依赖性内质网应激反应诱导自噬性细胞死亡,并为咪康唑的潜在抗增殖作用提供了新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号